Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of multiple doses of
TAK-875, once daily (QD), in subjects with Type 2 Diabetes Mellitus.